CTT Pharmaceutical Holdings, Inc. (CTTH)
OTCMKTS · Delayed Price · Currency is USD
0.0400
-0.0010 (-2.44%)
Aug 21, 2025, 4:00 PM EDT
CTTH Market Cap
CTTH has a market cap or net worth of $2.30 million as of August 22, 2025. Its market cap has decreased by -3.24% in one year.
Market Cap
2.30M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since September 11, 2014, CTTH's market cap has increased from 1.48M to 2.30M, an increase of 55.33%. That is a compound annual growth rate of 4.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 2.30M | -25.26% |
| Dec 31, 2024 | 3.07M | 113.42% |
| Dec 29, 2023 | 1.44M | 37.00% |
| Dec 30, 2022 | 1.05M | -38.67% |
| Dec 31, 2021 | 1.71M | -28.50% |
| Dec 31, 2020 | 2.40M | -74.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 633.65M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 594.33M |
| American Oncology Network | 385.33M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 367.18M |